Dr. Alan Green’s patients travel from around the country to his tiny practice in Queens, N.Y., lured by the prospect of longer lives.
Over the past two years, more than 200 patients have flocked to see Green after learning that two drugs he prescribes could possibly stave off aging. One 95-year-old was so intent on keeping her appointment that she asked her son to drive her from Maryland after a snowstorm had closed the schools.
Green is among a small but growing number of doctors who prescribe drugs “off-label” for their possible anti-aging effects. Metformin is typically prescribed for diabetes, and rapamycin prevents organ rejection after a transplant, but doctors can prescribe drugs off-label for other purposes—in this case, for “aging.”
Each eukaryotic chromosome has a loop at its end that is known as a telomere. This loop is composed of highly repeated DNA sequences and specialized binding proteins that protect the end the chromosome. The loss of one or more telomeres can lead to senescence or anueploidy, so cells must carefully r…
Leading transhumanists from a variety of backgrounds and perspectives provide concise, powerful statements as to why they are transhuman. The Transhuman Era has arrived; some of us are aware of this already, whereas others are transhuman but do not know it yet. The #IAmTranshuman campaign helps illustrate how emerging technologies and the accompanying shifts in thinking are already transforming everyday life.
This video was compiled and formatted by Tom Ross, the U.S. Transhumanist Party / Transhuman Party’s Director of Media Production: http://tomross.com/
The following transhumanists are featured, in order of appearance:
- B.J. Murphy, Director of Social Media, U.S. Transhumanist Party / Transhuman Party. - Ira Pastor, Regeneration Advisor, U.S. Transhumanist Party / Transhuman Party. - Tom Ross, Director of Media Production, U.S. Transhumanist Party / Transhuman Party. - José Luis Cordeiro, Technology Advisor and Ambassador to Spain, U.S. Transhumanist Party / Transhuman Party. - Charlie Kam, Director of Networking, California Transhumanist Party. - Bill Andrews, Biotechnology Advisor, U.S. Transhumanist Party / Transhuman Party. - Gennady Stolyarov II, Chairman, U.S. Transhumanist Party / Transhuman Party.
You can participate in the #IAmTranshuman campaign by submitting still images or video recordings of one minute or less (15 seconds or less for Instagram stories, one minute or less for Instagram-compatible videos). Use the hashtag #IAmTranshuman, and let us know if you would like your video included in a subsequent compilation!
SAN FRANCISCO (AP) — Ernest Quintana’s family knew he was dying of chronic lung disease when he was taken by ambulance to a hospital, unable to breathe.
But they were devastated when a robot machine rolled into his room in the intensive care unit that night and a doctor told the 78-year-old patient by video call he would likely die within days.
“If you’re coming to tell us normal news, that’s fine, but if you’re coming to tell us there’s no lung left and we want to put you on a morphine drip until you die, it should be done by a human being and not a machine,” his daughter Catherine Quintana said Friday.
In its most recent weekly US influenza surveillance report, the Centers for Disease Control and Prevention revealed that flu activity remains high across the nation. According to the agency, both the influenza A viruses H1N1 and H3N2, as well as influenza B viruses, are still making rounds through the population, with H3 viruses more frequently reported than H1N1.
The U.S. Food and Drug Administration has approved the first immunotherapy drug for breast cancer.
Continue Reading Below
Swiss drugmaker Roche’s Tecentriq was OK’d Friday for treating advanced triple-negative breast cancer, which accounts for about 15 percent of cases. It’s to be given with chemotherapy, the standard treatment.
As a passionate supporter of the advancement of women and recognition for their immense contributions to our world, I was thrilled to learn of a fascinating new initiative that launched today, in honor of International Women’s Day and Women’s History Month. This unique AI-powered web experience called https://www.nobelprize.org/womenwhochangedscience/” target=”_blank” rel=” nofollow noopener noreferrer” data-ga-track=” ExternalLink: https://www.nobelprize.org/womenwhochangedscience/”>Women Who Changed Science highlights the achievements of female Nobel Prize winners who broke new ground in physics, chemistry and medicine. Raising awareness of their tremendous impact, the initiative aims to empower the next generation of scientists.
Women Who Changed Science is an outgrowth of a new collaboration with Nobel Media and Microsoft and is one of Microsoft’s ongoing initiatives to build female inclusion and diversity in STEM fields. This new endeavor trains a lens on the inspiring journeys and contributions of female Nobel Prize winners who’ve significantly impacted our world for the better.
Never be limited by other people’s limited imaginations… If you adopt their attitudes, then the possibility won’t exist because you’ll have already shut it out… You can hear other people’s wisdom, but you’ve got to re-evaluate the world for yourself.
As a physician, Peace Corps volunteer, entrepreneur, teacher, dancer, and astronaut, Jemison has certainly lived her life in protest of people’s limited imaginations. Born in 1956, Jemison’s interest in STEM rooted early, and she enrolled at Stanford University when she was only 16. She majored in degrees in both chemical engineering and Afro-American studies, and she went on to receive an M.D. just four years later.
Jemison worked as a medical practitioner and served for two-and-a-half years in the Peace Corps as a medical officer. When she returned to the United States in 1985, she did something incredibly difficult: She pivoted her career entirely to pursue her childhood dream of becoming an astronaut. Jemison applied to the NASA astronaut training program, was selected from a field of 2,000 individuals, and in 1992, became the first African-American woman to go to space.
A new compound discovered by scientists at Scripps Research may prove to be a powerful weapon in the fight against one of the most aggressive and deadly types of cancer. Just like the cancer it fights, the compound is incredibly strong, selectively targeting the cells that allow glioblastoma multiforme (GBM) to rapidly take over the brain.
The research, which was published in a new paper in Proceedings of the National Academy of Sciences, explains how the stem-like cancer cells of GBM promote growth of the tumor while also aiding it in recurrence even after a patient has had surgery. Stopping these cells from doing their deadly deed is crucial to successful treatment, and the new compound — which the scientists have nicknamed RIPGBM — does just that.
